29.05.2024

Project Orbis: quicker access to promising cancer treatments

Scientific analysis confirms successful Swissmedic participation in international initiative to expedite access to innovative cancer drugs

28.05.2024

Swissmedic Vigilance News Edition 32

In this edition:
• Paclitaxel-induced cystoid macular oedema
• Chemotherapy-associated severe hypertriglyceridaemia
• Spider-like skin reactions following bortezomib (Velcade®)
• Potential increased risk of neurodevelopmental disorders (NDD) in children whose fathers were treated with valproate

28.05.2024

Daptomycin and eosinophilic pneumonia

Learning from adverse reaction reports – cases from pharmacovigilance

23.05.2024

DHPC – Entocort CIR (Budesonidum)

Fehlerhafte Dosierungsangabe im französischen Text der Packungsbeilage für die Langzeitanwendung zur Erhaltung der Remission bei Morbus Crohn

17.05.2024

Regulatory & Beyond 2024

Save the Date (26 November 2024)

17.05.2024

Publication with Swissmedic involvement on the risk assessment of nitrosamine impurities

Scientific article on the development and application of the "Carcinogenic Potency Categorisation Approach" (CPCA) published

08.05.2024

HPC – Mydocalm (Tolperison)

Tolperison: Einschränkung der Indikation und das Risiko von Überempfindlichkeitsreaktionen

03.05.2024

Bedarfsabklärung für Monographien

zu wässrigen Iod-Lösungen der Ph. Helv.

In focus

Reisen-mit-Medis

Holidaying in Switzerland

Which medications can be imported into Switzerland in which quantities?
Information on the entry requirements with medicinal products

Contact for members of the public

Do you have any questions about a particular medicine or a general question about Swissmedic? We’ll be glad to be of assistance. 

Just send an e-mail to anfragen@swissmedic.ch or use our contact form. Thank you.

Direct links


Stay up to date


Reporting undesirable effects and incidents

Medicines


Medical devices

Swiss Public Assessment Report (SwissPAR)

SwissPAR

Public Summary SwissPAR

Featured


Swissmedic video portrait

Swissmedic monitors all therapeutic products on the market in Switzerland. Our independent experts ensure the therapeutic products you and your loved ones need are effective, safe and of the highest quality.

Reporting of ADRs by healthcare professionals

Find out in the video how to report adverse drug reactions properly.

Reporting of ADRs by healthcare professionals

Incidents involving medical devices: find out in the video why every report counts!

Allgemein

01.11.2023

New medical devices regulations

Information concerning the new EU-Regulations as well as their implementation in Switzerland.

Revision of the MedDO and the IvDO
Information on the new EU Regulations and their implementation in Switzerland.

swissmedic-teaser-mep-video1-anim

What are the tasks of Swissmedic in the area of medical devices?

What is a medical device? How do medical devices come onto the market? How do you recognise a medical device? Based on examples, our videos answer these and a number of other questions.

Medical devices: List of Field Safety Corrective Actions (FSCA) and recalls

Swissmedic monitors all safety measures and recalls for medical devices that are manufactured or marketed in Switzerland.


Swissmedic, Swiss Agency for Therapeutic Products

swissmedic_hauptsitz-hallerstrasse7-bern_03

Swissmedic – for therapeutic products you can trust

Swissmedic is the Swiss authority responsible for the authorisation and supervision of therapeutic products. Swissmedic's activities are based on the Law on Therapeutic Products.

For further information...
https://www.swissmedic.ch/content/swissmedic/en/home.html